FDA Approval of GPRC5D-Targeting Bispecific Antibody Talquetamab for Patients With R/R MM

Press/Media

Period	21 Aug 2023

Media coverage

Title	FDA Approval of GPRC5D-Targeting Bispecific Antibody Talquetamab for Patients With R/R MM
Media name/outlet	HMP Global Learning Network
Country/Territory	United States
Date	21/08/23
URL	https://www.hmpgloballearningnetwork.com/site/onc/videos/fda-approval-gprc5d-targeting-bispecific-antibody-talquetamab-patients-rr-mm
Persons	Ajai Chari